June 23, 2011

Sanofi Pasteur’s Typhoid Vaccine, Typhim Vi®, Granted Prequalification by the World Health Organization

- Designation will facilitate global access to vaccine for the prevention of typhoid fever in the most vulnerable populations around the world -

 

Sanofi Pasteur’s Typhoid Vaccine, Typhim Vi®, Granted Prequalification by the World Health Organization
- Designation will facilitate global access to vaccine for the prevention of typhoid fever in the most vulnerable populations around the world -

Lyon, France – June 23, 2011 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the World Health Organization (WHO) has granted prequalification to its Typhim Vi® polysaccharide typhoid vaccine. Typhim Vi® is the first WHO prequalified typhoid vaccine.